A cute lung injury (ALI) is a common cause of life-threatening acute respiratory failure in children and adults. ALI is characterized by activation of the pulmonary endothelium, disruption of endothelial and alveolar epithelial barriers, and an increase in microvascular permeabil-ity, resulting in protein-rich pulmonary edema (1) . Although the exact pathogenetic mechanisms of this clinical disorder are unknown, an understanding of these mechanisms is critical for the development of novel therapies (2) . Identification of cell-specific biological markers with levels that are up-regulated or downregulated in early ALI can provide such insight.
Vascular growth factors, such as angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2), have been proposed as biological markers for ALI. Ang-1 and Ang-2 classically act in an agonist/antagonist manner on the endothelial tyrosine kinase receptor, Tie-2 (3). Ang-1 stabilizes the endothelium by inhibiting endothelial cell apoptosis and activation and decreasing inflammation (4 -9) . In contrast, Ang-2 is a context-dependent antagonist to the Tie-2 receptor that is proinflammatory and promotes endothelial and epithelial cell apoptosis, increases neutrophil adhesion, and causes cytoskeletal changes to increase interendothelial gaps (10 -15) . In concert, the two angiopoietins may act directly or indirectly to change the integrity of the vascular endothelium. Given the critical role of endothelial disruption in the formation of protein-rich pulmonary edema fluid, alterations in Ang-1 and Ang-2 may be associated with the pathogenesis of ALI.
Although recent studies have demonstrated an association of plasma levels of Ang-1 and Ang-2 with poor clinical outcomes in critically ill patients (15) (16) (17) (18) , angiopoietin studies specific to ALI patients have been more limited. Higher levels of Ang-2 are found in the pulmonary edema fluid from ALI patients, compared with hydrostatic pulmonary edema fluid (19) . Gallagher et al (14) reported elevated levels of Ang-2 in nonsurvivors of ALI and a rescue effect of Ang-1 on endothelial cells disrupted by plasma with a high concentration of Ang-2. These results suggest that elevations in Ang-2 and decreases in Ang-1 may reflect a proinflammatory state best summarized by the ratio of Ang-2 to Ang-1. Given this previous evidence, we hypothesized that the concentration of Ang-2 relative to Objective: To test the hypothesis that the concentration of angiopoietin-2 relative to angiopoietin-1 may be a useful biological marker of mortality in acute lung injury patients. We also tested the association of concentration of angiopoietin-2 relative to angiopoietin-1 with physiologic and biological markers of activated endothelium.
Design: Prospective, observational cohort study. Setting: Intensive care units in a tertiary care university hospital and a university-affiliated city hospital.
Patients: Fifty-six mechanically ventilated patients with acute lung injury.
Interventions: Baseline plasma samples and pulmonary deadspace fraction measurements were collected within 48 hrs of acute lung injury diagnosis.
Measurements and Main Results: Plasma levels of angiopoietin-1 and angiopoietin-2 and of biomarkers of endothelial activation were measured by enzyme-linked immunosorbent assay. Baseline concentration of angiopoietin-2 relative to angiopoietin-1 was significantly higher in patients who died (median, 58
[interquartile range, 17-117] vs. 14 [interquartile range, 6 -35]; p ‫؍‬ .01). In a multivariable analysis stratified by dead-space fraction, concentration of angiopoietin-2 relative to angiopoietin-1 was an independent predictor of death, with an adjusted odds ratio of 4.3 (95% confidence interval, 1.3-13.5; p ‫؍‬ .01) in those with an elevated pulmonary dead-space fraction (p ‫؍‬ .03 for interaction between pulmonary dead-space fraction and concentration of angiopoietin-2 relative to angiopoietin-1). Moderate to weak correlation was found with biological markers of endothelial activation.
Conclusions: The ratio of concentration of angiopoietin-2 relative to angiopoietin-1 may be a prognostic biomarker of endothelial activation in acute lung injury patients and, along with pulmonary dead-space fraction, may be useful for risk stratification of acute lung injury patients, particularly in identifying subgroups for future research and therapeutic trials. (Crit Care Med 2010; 38:1845-1851) KEY WORDS: acute lung injury; acute respiratory distress syndrome; angiopoietin; predictor; pulmonary dead-space fraction; endothelial activation
Ang-1 may be associated with the degree of endothelial injury in ALI. Our primary objective was to test the association between the Ang-2/Ang-1 ratio and clinical outcomes in ALI patients. The second objective was to test the association of the Ang-2/ Ang-1 ratio with physiologic and biological markers of activated endothelium.
MATERIALS AND METHODS

Subjects and Patient Samples
Fifty-six patients who met the American-European Consensus definition for ALI or acute respiratory distress syndrome (ARDS) (20) were prospectively enrolled from a tertiary care university hospital (Moffitt-Long University Hospital) and a university-affiliated city hospital (San Francisco General Hospital) from 2003 to 2007. Patients were enrolled within 48 hrs of ALI/ARDS diagnosis. Eligible patients were mechanically ventilated and had an arterial line in place. Exclusion criteria were age younger than 18 yrs, prisoners, pregnancy, patients involuntarily admitted for psychiatric reasons, a history of severe chronic obstructive pulmonary disease asthma, chronic interstitial lung disease or pulmonary vascular disease, recent pulmonary embolism, acute myocardial infarction within 30 days, history of congestive heart failure, lack of surrogate available for consent, or not committed to aggressive care. The study was approved by the institutional review boards of both hospitals and written informed consent was obtained for all subjects.
Clinical Data and Outcomes
Clinical data were abstracted from the medical record. Acute Physiology and Chronic Health Evaluation (APACHE) II scores (21) were calculated at baseline. Ventilator data, including measurement of pulmonary deadspace fraction (22, 23) , were recorded for each subject at the time of baseline plasma sample collection. Pulmonary dead-space fraction measurements could not be obtained for three patients. The primary outcome was 28-day inhospital mortality.
Plasma Biomarker Measurements
Baseline plasma samples were collected at the time of enrollment in heparinized tubes. After centrifugation, the plasma aliquots were stored at Ϫ70°C until the time of analysis. Levels of Ang-1, Ang-2, and receptor for advanced glycation end products were measured in duplicate using commercially available enzyme-linked immunosorbent assay kits (R&D Systems, Minneapolis, MN). Plasma levels of biomarkers of inflammation and disordered coagulation and fibrinolysis, specifically interleukin-6, interleukin-8, thrombomodulin, von Willebrand factor antigen, intercellular adhesion molecule-1, protein C, and plasminogen activator inhibitor-1, have previously been reported in a subset of patients in this cohort (24) , and these values were used for some of the analyses.
Statistical Analyses
Analysis was conducted with STATA 10.0 (College Station, TX). A two-sided p Ͻ .05 was considered significant unless otherwise specified. Plasma Ang-1, Ang-2, and Ang-2/Ang-1 levels were not normally distributed, so data were compared between survivors and nonsurvivors using a nonparametric test (Mann-Whitney rank sum). To test for a nonlinear effect of Ang-2/Ang-1 on mortality, we divided Ang-2/Ang-1 into tertiles and used a nonparametric test to test for trends (Cuzick trend test). To test the association of the Ang-2/ Ang-1 ratio with mortality, we applied a natural log-transformation to the Ang-2/Ang-1 ratio and initially created an unadjusted logistic regression model.
For multivariable analysis, we considered baseline clinical features that may have affected outcomes, including age, gender, PaO 2 / FIO 2 , tidal volume, plateau pressure, and severity of illness, as measured by the APACHE II score (21) . Predictors were eliminated from the model using backward, stepwise regression; all predictors with p Ͻ .3 were retained in the final model, as well as age, gender, and APACHE II score for face validity. Because of an observed interaction with Ang-2/Ang-1 ratio and pulmonary dead-space fraction, analyses were stratified by pulmonary dead-space fraction. For more thorough analysis, we estimated the prognostic significance of Ang-2/ Ang-1 by high-and low-pulmonary dead-space fraction with the interaction term present in a single model of all patients. This was the only interaction tested and sought because pulmonary dead-space fraction may be, in part, a physiologic marker of endothelial activation (25) ; for potentially significant interactions, p Ͻ 0.1. Model specification was evaluated using the link test (26) , and model fit was evaluated using the Hosmer-Lemeshow goodness-of-fit test (27) .
Spearman rank-correlation coefficients were used to correlate the ratio of Ang-2/ Ang-1 with known biomarkers of ALI. Biomarkers levels were not normally distributed, and a natural log transformation was applied before assessment in a backward, step-wise logistic regression model. Likelihood ratio testing was used to test the contribution of Ang-2/Ang-1 to the area under the receiver operating characteristic (ROC) curve for the logistic regression model (28, 29) .
RESULTS
Baseline Clinical Characteristics and Ang Levels
Baseline characteristics of the 56 study subjects are summarized in Table 1 . The overall in-hospital mortality in the cohort was 34%. Baseline plasma Ang-1 and Ang-2 levels were compared in survivors (n ϭ 37) and nonsurvivors (n ϭ 19). There was a trend toward lower baseline Ang-1 levels in nonsurvivors compared with survivors, although this did not reach statistical significance (median, 98 pg/mL; interquartile range [IQR], 74 -156 pg/mL vs. 140 pg/mL; IQR, 93-282 pg/ mL; p ϭ .09). Baseline Ang-2 levels were higher in nonsurvivors compared with survivors (median, 6300 pg/mL; IQR, 2653-10,200 pg/mL vs. 2900 pg/mL; IQR, 1406 -4732 pg/mL; p ϭ .01). Baseline Ang-2/Ang-1 ratio was significantly higher in nonsurvivors compared with survivors (median, 58; IQR, 17-117 vs. 14; IQR, 6 -35; p ϭ .01; Figure 1 ). 
Higher Ang-2/Ang-1 Ratio Is Associated With Mortality in ALI Patients
In univariate analysis, baseline plasma Ang-2/Ang-1 ratio was significantly associated with death (odds ratio [OR], 1.9; 95% confidence interval [CI], 1.2-3.2; p ϭ .01). Figure 2 summarizes the observed mortality by tertile of baseline Ang-2/Ang-1 ratio. In comparison with the overall mortality of 34%, a categorical increase in death was observed from 15% in the lowest tertile to 60% in the highest tertile, with a significant test for trend across tertiles (p ϭ .004). On further analysis of the association between baseline Ang-2/Ang-1 ratio and death, we detected a significant interaction between Ang-2/Ang-1 and pulmonary dead-space fraction, a physiologic marker of endothelial activation (p ϭ .03). Therefore, we divided patients into groups with highand low-pulmonary dead-space fractions based on the mean pulmonary dead-space fraction (0.58) from a large previous study that demonstrated that increased dead-space fraction is associated with higher mortality in patients with ALI/ ARDS (25) . Baseline plasma Ang-2/Ang-1 ratio was strongly associated with death only in patients who had a high level of pulmonary dead-space fraction (OR, 4.7; 95% CI, 1.5-14.7; p ϭ .009; Fig. 3 ). Ang-2/Ang-1 ratio was not predictive of death in patients with a lower level of pulmonary dead-space fraction (OR, 1.1; 95% CI, 0.5-2.1; p ϭ .89). Results did not change with linear estimation in a single model of all patients including the interaction term. In addition, pulmonary dead-space fraction independent of Ang-2/Ang-1 was not associated with increased odds of death (OR, 0.7; 95% CI, 0.1-9.5; p ϭ .8).
Multivariable Models
The association between plasma Ang-2/Ang-1 ratio and death persisted in multivariate models. In the initial analysis, the predictors included in the model were baseline Ang-2/Ang-1 ratio, age, gender, APACHE II score, PaO 2 /FIO 2 ratio, tidal volume, and plateau pressure. Predictors for retention in the final model were selected using a backward, stepwise approach in the overall cohort. Apart from the baseline Ang-2/Ang-1 ratio, the APACHE II score and the PaO 2 /FIO 2 ratio also were selected as independent predictors for death in the overall cohort (data not shown). Given the significant interaction of pulmonary dead-space fraction with baseline Ang-2/Ang-1 ratio, we subsequently stratified our multivariable analysis of the association of Ang-2/Ang-1 ratio with death by pulmonary dead-space fraction. Higher baseline plasma Ang-2/ Ang-1 was the only independent predictor of death, with an adjusted OR of 5.5 (95% CI, 1.2-24.9; p ϭ .03; Table 2 ) in those with a higher pulmonary dead-space fraction. Misspecification of the model was not present as assessed by link test (p ϭ .81). The Hosmer-Lemeshow test indicated that the model was not overfit (p ϭ .31). To test for potential clinical utility of Ang-2/Ang-1 in this model, we constructed ROC curves. The predictive accuracy of the model of clinical and physiologic variables alone (APACHE II score, age, gender, PaO 2 /FIO 2 ratio, tidal volume, and plateau pressure) was modest, as evidenced by area under the ROC curve (0.79). With Ang-2/Ang-1 added to the model, the area under the ROC curve increased to 0.92, with a significant contribution by likelihood ratio testing (p ϭ .003). We specifically chose not to adjust for sepsis in our multivariate model because one of the pathogenic mechanisms of sepsis-related ALI may be through disruption of the vascular endothelium mediated by levels of angiopoietins; thus, if Ang-2/Ang-1 mediates the impact of sepsis on outcomes, adjusting for sepsis in the model would eliminate the opportunity to test Ang-2/Ang-1 as a prognostic predictor. There was no significant association between baseline Ang-2/Ang-1 ratio and mortality in patients with low pulmonary dead-space fraction.
Ang-2/Ang-1 Ratio Is Associated With Biological Markers of Endothelial Activation
The higher pulmonary dead-space fraction in ALI may be attributable to endothelial activation and microvascular thrombosis. Given the significant interaction of elevated Ang-2/Ang-1 ratio and high-pulmonary dead-space fraction, we tested the association between the Ang-2/ Ang-1 ratio and known biomarkers associated with poor clinical outcomes and endothelial activation, as well as other specific pathways of lung injury. A moderate and highly significant correlation was found with thrombomodulin, a marker of activated endothelium (r s ϭ .64; p Ͻ .0001). Significant, but weaker, correlation was found with other markers of activated endothelium, namely, von Willebrand factor, intercellular adhesion molecule-1, and lower levels of protein C ( Table 3 ). Moderate to weak correlation was also found with markers of systemic inflammation, interleukin-8, and interleukin-6, but there was no significant correlation with the alveolar epithelial injury marker receptor for advanced glycation end products.
We used backward, step-wise logistic regression to test whether the Ang-2/ Ang-1 ratio was an independent predictor of mortality when included in a model with these other biological markers. Ang- 2/Ang-1 remained in the model as an independent predictor of mortality, although the confidence interval widened (OR, 10; 95% CI, 1.3-80; p ϭ .04). Other independent predictors that remained in the model included markers of disordered coagulation (plasminogen activator inhibitor-1, protein C), alveolar epithelial injury (receptor for advanced glycation end products), and systemic inflammation (interleukin-6). To examine the contribution of the Ang-2/Ang-1 ratio in relation to these other biological markers, we tested the model with and without Ang-2/Ang-1. The area under the ROC curve increased to 0.97 from 0.91 when Ang-2/Ang-1 was included in the model. The contribution of the Ang-2/Ang-1 ratio to the logistic model was significant by likelihood ratio testing (p ϭ .0008), and the model was not overfit by the Hosmer-Lemeshow test (p ϭ .99).
DISCUSSION
In this study, a higher Ang-2/Ang-1 ratio was an independent predictor of mortality in ALI patients even after adjustment for known clinical and physiologic variables associated with poor outcomes, including age and severity of illness. There was a significant interaction between the pulmonary dead-space fraction and the Ang-2/Ang-1 ratio; that is, the predictive value of the Ang-2/ Ang-1 ratio for mortality differed by level of the pulmonary dead-space fraction. In patients with high-pulmonary dead-space fraction, the Ang-2/Ang-1 ratio was significantly elevated in nonsurvivors and the only predictor of mortality in a multivariate model. Ang-2/Ang-1 made a significant contribution to the predictive accuracy of this model of clinical parameters with an increase in the area under the ROC curve from 0.79 to 0.92. Furthermore, Ang-2/Ang-1 was also associated with biological markers of endothelial injury and activation, but not epithelial injury, and remained an independent predictor of mortality in a multivariable model controlling for these biological markers. In aggregate, these results indicate that the ratio of Ang-2/ Ang-1 may be a useful prognostic marker of endothelial activation in ALI patients with higher dead-space fraction, linking plasma biomarker measurements of endothelial activation with a physiologic measure of ALI severity.
The association of the Ang-2/Ang-1 ratio with endothelial activation and injury is reinforced by a growing body of evidence in both animal and in vitro models (10, 11, 30 -32) . Stimulation of microvascular endothelial cells in the lung has been shown to release Ang-2; incubation with Ang-1 attenuates the release of Ang-2 (32) . Ang-2 also has been associated with vascular leakage in inflammatory settings (10) . Despite this evidence, the cellular source of Ang-1 and Ang-2 remains controversial. Bhandari et al reported epithelial production of Ang-2 in a mouse model of hyperoxic lung injury, whereas others have suggested an endothelial source (19, 31) . We thus measured Ang-2/Ang-1 in association with several biomarkers to assess cellular compartments of ALI, including receptor for advanced glycation end products as a marker of epithelial injury. Our results suggest that Ang-2/Ang-1 reflects endothelial, not epithelial, injury. Although the source of Ang-1 and Ang-2 in the plasma cannot be determined from the current study, the association between lower levels of Ang-1 and higher levels of Ang-2 with severity of ALI/ARDS suggests that the relative levels of these two mediators may be important determinants of the severity of endothelial injury.
Our results are consistent with and expand on previous human studies. Plasma levels of Ang-2 were higher in trauma patients with ALI/ARDS in comparison to controls (34) , and Ang-2 was the only biomarker of endothelial injury identified in a diagnostic panel of biomarkers that differentiated ALI from non-ALI. Also, serum Ang-2 levels were significantly increased in severe sepsis compared with controls (35) . Ang-2 levels were higher in patients with septic shock compared with septic patients without shock, and Ang-2 levels were associated with adverse clinical outcomes (33) . In patients with ALI/ARDS, higher Ang-2 levels were associated with increased pulmonary leak of 67 Gallium-transferrin, and Ang-2 levels correlated with plasma von Willebrand factor, a marker of endothelial injury (16, 34) . In another study, the same group reported that plasma levels of the soluble angiopoietin-binding Tie-2 receptor were elevated in sepsis but did not affect the relationship between Ang-1, Ang-2, and pulmonary leak (35) .
The significant interaction of the pulmonary dead-space fraction and the ratio of Ang-2/Ang-1 in this study suggests a potential biological impact of Ang-2/ Ang-1 in the setting of greater endothelial activation in patients with ALI. En-dothelial injury of the pulmonary microcirculation and resulting thrombosis have been well-described in ALI pathophysiology and may partly account for an elevation in the dead-space fraction in ALI patients (25, 36) . Although other mechanisms including intrapulmonary shunt and low cardiac output have been reported to contribute to an increase in the dead-space fraction (37-40), Dixon et al (41) reported an association of increased dead-space fraction with prothrombin fragment production in the pulmonary circulation in cardiac surgery patients. This group also reported a decrease in pulmonary dead-space fraction with infusion of preoperative heparin, supporting dead-space fraction as a physiologic marker of activated endothelium and microvascular thrombosis. The current study demonstrates a significant correlation of the ratio of Ang-2/Ang-1 with plasma levels of soluble thrombomodulin, suggesting that an elevated ratio of Ang-2/Ang-1 in patients with a highpulmonary dead-space fraction may reflect severe endothelial injury with prognostic implications.
This study has some limitations. Ang-2 and Ang-1 production may not be exclusively derived from the pulmonary endothelium. Bhandari et al (19) demonstrated Ang-2 expression in mouse epithelial cells. Ang-2 has also been shown to be context-dependent as an agonist or antagonist of the Tie-2 receptor, and its role may depend on other growth factors, such as vascular endothelial growth factor-A (3). We did not measure vascular endothelial growth factor-A in our cohort and cannot confirm its role in association with Ang-2. However, we considered the ratio of Ang-2/Ang-1, which can be considered a measure of relative antagonism and agonism to the Tie-2 receptor. Our cohort is modest in size, which limits us from making broad conclusions from our data. Pulmonary dead-space fraction independent of Ang-2/Ang-1 in our cohort was not associated with increased odds of death, and we may have been underpowered to detect this difference. There are also several clinical disorders that occur in association with ALI that disrupt the vascular endothelium and may alter Ang levels. Gene-environment interaction may be a contributing factor to ARDS risk, as suggested by associations between polymorphisms in the Ang-2 gene and ARDS susceptibility, particularly in patients with extrapulmonary injury (42). However, we did find an independent as-sociation of Ang-2/Ang-1 with mortality after adjustment for known clinical and physiologic variables and recommend validation of the Ang-2/Ang-1 ratio as a prognostic factor in patients with ALI in a larger cohort to confirm and extend these findings. Future studies should test the association of Ang-2/Ang-1 with other markers of endothelial permeability, including airspace-to-plasma protein ratios and measurements of extravascular lung water.
This study demonstrates that the ratio of Ang-2 to Ang-1 is an independent predictor of mortality in patients with ALI and markedly elevated pulmonary deadspace fraction, after adjustment for multiple clinical and physiologic predictors of poor outcomes in this disease. The ratio of Ang-2 to Ang-1 may be a useful prognostic biomarker of endothelial activation in ALI patients, particularly in combination with measurements of the pulmonary dead space. Higher Ang-2/ Ang-1 ratio may be useful for risk stratification of ALI patients, particularly in identifying subgroups for future research and therapeutic trials.
